Abstract
BACKGROUND: Intrathecal (IT) neostigmine has been used as an adjunct to spinal anesthesia. The purpose of this study was to determine whether a combination of low-dose neostigmine IT would enhance analgesia of a xed dose of fentanyl IT, in patients undergoing lower abdominal and lower limb surgeries To e AIM: valuate the analgesic efcacy of low dose intrathecal Neostigmine in combination with Fentanyl and Bupivacaine for lower abdominal and lower limb surgeries. OBJECTIVES: 1. To compare the onset of sensory and motor blockade. 2. To evaluate the piont of maximum sensory blockade. 3. To assess the VAS pain score,rst rescue analgesia time and adverse effects. METHODOLOGY: After obtaining approval from institutional ethics committe and informed consent,50 patients with ASA class I and II patients posted for elective lower abdominal and lower limb surgeries were selected and randomly divided into two gruops. GROUP A: Intrathecal Bupivacaine 12.5mg(2.5ml)+Fentany 20mcg (0.4ml)+ Normal saline (0.1ml) (Total 3ml). GROUP B: Intrathecal Bupivacaine 12.5mg(2.5ml)+Fentany 20mcg (0.4ml)+ Neostigmine 1mcg (0.1ml) (Total 3ml). Statistical analysis wa RESULTS: s done with paired t-test,student t test and chi square test .The p-valve p<0.005 was considered statistically signicant.Both the groups showed statistically signicant differance in terms of sensory blockade and recovery of sensory blockade.Group B showed the early onset of sensory blockade and prolonged recovery time. CONCLUSION : Intrathecal neostigmine precipitated the onset of motor and sensory blockade and prolongs the block signicantly when used with Bupivacaine and Fentanyl in spinal anaesthesia in a low dose.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have